CASI Pharma (CASI) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts CASI Hot Sheet
Join SI Premium – FREE
CASI Pharma (NASDAQ: CASI) reported Q4 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03).
For earnings history and earnings-related data on CASI Pharma (CASI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Vera Bradley (VRA) Tops Q2 EPS by 10c ; Offers Guidance
- Astrana Health (ASTH) Mentioned as short at Glass House
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
